Weekly taxanes in metastatic breast cancer (Review)

Author(s):  
Matteo Zimatore ◽  
Marco Danova ◽  
Erasmo Vassallo ◽  
Camillo Porta ◽  
Maria Catena Macaluso ◽  
...  
2015 ◽  
Vol 2 (2) ◽  
pp. 159-170 ◽  
Author(s):  
Nicolae Bacalbaşa ◽  
Sorin Tiberiu Alexandrescu ◽  
Irinel Popescu

Author(s):  
Mahsa Taskindoust ◽  
Samantha M. Thomas ◽  
Sarah Sammons ◽  
Oluwadamilola M. Fayanju ◽  
Gayle DiLalla ◽  
...  

Author(s):  
Mahsa Taskindoust ◽  
Samantha M. Thomas ◽  
Sarah L. Sammons ◽  
Oluwadamilola M. Fayanju ◽  
Gayle DiLalla ◽  
...  

2020 ◽  
Vol 89 ◽  
pp. 102066
Author(s):  
Johny E. Fares ◽  
Paul El Tomb ◽  
Lana E. Khalil ◽  
Rula W. Atwani ◽  
Hiba A. Moukadem ◽  
...  

2007 ◽  
Vol 3 (5) ◽  
pp. 523-528 ◽  
Author(s):  
Gaston Demonty

The aim of this review is to examine the evidence available supporting the use of the docetaxel plus trastuzumab combination for patients with HER-2-positive metastatic breast cancer. The results of trials involving this combination are summarized, with an emphasis on efficacy and cardiotoxicity data. Finally, this article attempts to identify areas of uncertainty where new trials are warranted to improve our knowledge regarding optimal care for patients with HER-2-positive metastatic breast cancer.


Sign in / Sign up

Export Citation Format

Share Document